Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancerJul 14, 2025 | Francisco Javier Casas Nebra, Publicaciones científicas, Sergio Vazquez-Estevez
Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancerSep 12, 2024 | Francisco Javier Casas Nebra, Publicaciones científicas, Sergio Vazquez-Estevez
